Canada markets closed

Sumitomo Pharma Co., Ltd. (DNPUF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.3150-0.3850 (-14.26%)
At close: 03:21PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 964.79M
Enterprise Value 3.37B
Trailing P/E N/A
Forward P/E 15.22
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.50
Price/Book (mrq)0.48
Enterprise Value/Revenue 0.01
Enterprise Value/EBITDA -0.03

Trading Information

Stock Price History

Beta (5Y Monthly) 0.59
52-Week Change 3-54.24%
S&P500 52-Week Change 325.77%
52 Week High 35.9000
52 Week Low 32.2700
50-Day Moving Average 32.4700
200-Day Moving Average 33.1748

Share Statistics

Avg Vol (3 month) 3808
Avg Vol (10 day) 3900
Shares Outstanding 5397.29M
Implied Shares Outstanding 6406.6M
Float 8179.4M
% Held by Insiders 157.59%
% Held by Institutions 116.56%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.1
Forward Annual Dividend Yield 44.05%
Trailing Annual Dividend Rate 37.00
Trailing Annual Dividend Yield 3259.26%
5 Year Average Dividend Yield 4N/A
Payout Ratio 487.75%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 30, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -52.59%
Operating Margin (ttm)-37.93%

Management Effectiveness

Return on Assets (ttm)-11.64%
Return on Equity (ttm)-34.90%

Income Statement

Revenue (ttm)330.31B
Revenue Per Share (ttm)831.40
Quarterly Revenue Growth (yoy)-41.60%
Gross Profit (ttm)N/A
EBITDA -188.88B
Net Income Avi to Common (ttm)-173.72B
Diluted EPS (ttm)-2.8600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)42.81B
Total Cash Per Share (mrq)107.75
Total Debt (mrq)411.84B
Total Debt/Equity (mrq)119.86%
Current Ratio (mrq)0.63
Book Value Per Share (mrq)864.73

Cash Flow Statement

Operating Cash Flow (ttm)-275.33B
Levered Free Cash Flow (ttm)-152.23B